The pumps’ original instructions “do not adequately address precautions” clinicians should bear in mind when using the device in patients who have had TAVRs, the FDA said. If the distal stent’s motor impeller blades are damaged, broken blades can enter a patient’s bloodstream, or the pump can stop or delay.
As of July 27, 30 complaints and 26 injuries have been reported. The correction is labeled as a Class I event.
Abiomed is not recalling the product; additional instructions were sent to customers and the device can be used.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.